Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Xponential Fitness Inc Cl A (NY: XPOF )

12.09 +0.04 (+0.33%)
Official Closing Price Updated: 7:00 PM EDT, Oct 15, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 271,127
Open 12.13
Bid (Size) 11.76 (1)
Ask (Size) 12.50 (10)
Prev. Close 12.05
Today's Range 11.97 - 12.51
52wk Range 7.400 - 18.95
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
OneMedNet Announces Board Member Transition to Drive Growth Post-IPO
From OneMedNet Corporation
Via GlobeNewswire
Kaskela Law LLC Announces Shareholder Investigation of Xponential Fitness, Inc. (NYSE: XPOF) and Encourages Long-Term XPOF Shareholders to Contact the Firm
From Kaskela Law LLC
Via Business Wire

Performance

YTD
-4.43%
-4.43%
1 Month
-11.75%
-11.75%
3 Month
-33.43%
-33.43%
6 Month
-11.30%
-11.30%
1 Year
-15.34%
-15.34%

More News

Read More
Xponential Fitness, Inc. Announces Upcoming Conference Participation
From Xponential Fitness, Inc.
Via Business Wire
XPONENTIAL ALERT: Bragar Eagel & Squire, P.C. is Investigating Xponential Fitness, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Xponential Fitness (XPOF) Q2 2024 Earnings Call Transcript
Via The Motley Fool
Topics Earnings
Exposures Financial
Xponential Fitness, Inc. Announces Second Quarter 2024 Financial Results
From Xponential Fitness, Inc.
Via Business Wire
Xponential Fitness, Inc. to Announce Second Quarter 2024 Financial Results on Thursday, August 1, 2024
From Xponential Fitness, Inc.
Via Business Wire
12 Consumer Discretionary Stocks Moving In Thursday's After-Market Session
Via Benzinga
Why Xponential Fitness Stock Skyrocketed Today
Via The Motley Fool
Why Ovid Therapeutics Shares Are Trading Lower By 19%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
12 Consumer Discretionary Stocks Moving In Monday's Intraday Session
Via Benzinga
Why Xponential Fitness Shares Are Surging On Monday
Via Benzinga
Aaron's, Nvidia, Mirum Pharmaceuticals, Primo Water And Other Big Stocks Moving Higher On Monday
Via Benzinga
Xponential Fitness Announces Appointment of Mark King as Chief Executive Officer
From Xponential Fitness, Inc.
Via Business Wire
12 Consumer Discretionary Stocks Moving In Thursday's Intraday Session
Via Benzinga
Why G-III Apparel Shares Are Trading Lower By 13%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
J.M. SmuckerPosts Upbeat Earnings, Joins Toro Company, United Natural Foods, Semtech And Other Big Stocks Moving Higher On Thursday
Via Benzinga
Xponential Fitness and the American Cancer Society Collaborate to Recognize National Cancer Survivors Month in June
From Xponential (Consumer)
Via Business Wire
A New Name in Weight Loss Drugs
Via The Motley Fool
Xponential Fitness, Inc. Announces Divestiture of Row House
From Xponential Fitness, Inc.
Via Business Wire
Xponential Fitness, Inc. Announces Upcoming Conference Participation
From Xponential Fitness, Inc.
Via Business Wire
Xponential Fitness Provides Update on Leadership Transition
From Xponential Fitness, Inc.
Via Business Wire
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Xponential Fitness, Inc. (XPOF) on Behalf of Investors
From Glancy Prongay & Murray LLP
Via Business Wire
XPONENTIAL ALERT: Bragar Eagel & Squire, P.C. is Investigating Xponential Fitness, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
12 Consumer Discretionary Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.